portfolio
team
news
Portfolio
During their long careers in venture capital, members of the team have been involved in the management of over 5 venture capital partnerships through multiple market cycles. Including their activities at previous firms, the team has been involved with over 40 healthcare investments (originating many of these deals), many of which have been acquired or completed IPOs. Most recently, the team led a number of successful investments during their tenure at Asset Management Company, and continues to manage several of these investments.
BioMimedica is developing a new approach to joint repair through the use of synthetic cartilage. *Private
BiPar is a biopharmaceutical company developing a new class of cancer therapies based on a novel mechanism with broad therapeutic potential against a wide range of cancers. *Acquired by sanofi-aventis (NYSE: SNY)
Chimerix develops new anti-viral treatments that are focused on infectious disease such as smallpox and HIV. *Private
Enteric has developed minimally invasive surgical treatments for gastro-esophageal reflux disease ("GERD"). *Acquired by Boston Scientific (NYSE: BSX)
EndoVx is developing a novel medical device system for non-invasively treating obesity. *Private
Fusion Medial developed surgical sealants to halt arterial bleeding. *Acquired by Baxter International (NYSE: BAX)
InteKrin Therapeutics is pursuing the clinical development of therapeutics for diabetes, obesity and metabolic disorders. *Private
Invuity is pioneering illuminated surgical access solutions for improving visualization and enabling less invasive medical procedures. *Private
iScience Interventional has develop and is marketing an image-guided surgical system for the treatment of glaucoma. *Private
Koronis Pharmaceuticals develops technologies for the prevention and treatment of chronic viral diseases: HIV, HBV and HCV. *Private
MicroVention developed catheter-based technologies for the endovascular treatment of cerebral and peripheral vascular diseases. *Acquired by Terumo Corporation (Japan)
Novare Surgical is a developer of proprietary medical devices for temporary occlusion management and one-port endoscopic surgery. *Private
Proteus Biomedical is developing a broad range of in-body computing products: next generation cardiac rhythm management systems, intelligent medicines and hospital systems. *Private
Sonoma Orthopedics has developed and is marketing a unique implant device for fixation of long bone fractures. *Private
Trivascular developed next-generation transluminally placed endovascular grafts, often referred to as stent-grafts, for the treatment of aneurysmal disease in the abdominal aorta (AAA) and the thoracic aorta (TAA). *Acquired by Boston Scientific (NYSE: BSX)